MDCO

The Medicines Company News Headlines

$22.04
*  
0.28
1.25%
Get MDCO Alerts
*Delayed - data as of Oct. 1, 2014 11:48 ET  -  Find a broker to begin trading MDCO now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    MDCO Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Lannett Shares Down on Subpoena Receipt from Connecticut AG - Analyst Blog
7/17/2014 5:10:00 PM - Zacks.com

Rigel Pharmaceuticals Starts Fostamatinib Late Stage Program - Analyst Blog
7/17/2014 4:45:00 PM - Zacks.com

Hospira Upgraded to Strong Buy on Orchid Facility Buy - Analyst Blog
7/15/2014 5:00:00 PM - Zacks.com

Sunesis' Pediatric Plan Accepted in the EU - Analyst Blog
7/14/2014 6:45:00 PM - Zacks.com

Cytokinetics Up on Positive Tirasemtiv Data - Analyst Blog
7/14/2014 5:00:00 PM - Zacks.com

Hefty Price Tag of Gilead's Sovaldi Questioned Again - Analyst Blog
7/14/2014 11:30:00 AM - Zacks.com

Bristol-Myers to Seek U.S. Approval for Immuno-Oncology Drug - Analyst Blog
7/11/2014 5:30:00 PM - Zacks.com

Sarepta Plunges on Eteplirsen Study Results - Analyst Blog
7/11/2014 5:00:00 PM - Zacks.com

Celgene's Otezla Disappoints in Ankylosing Spondylitis Study - Analyst Blog
7/10/2014 11:30:00 AM - Zacks.com

BioMarin's Vimizim Gets Canadian Nod - Analyst Blog
7/8/2014 6:10:00 PM - Zacks.com

BioDelivery Jumps after Pain Drug Performs Well in Study - Analyst Blog
7/8/2014 4:45:00 PM - Zacks.com

BIND Therapeutics (BIND) in Focus: Stock Tumbles 10.0% - Tale of the Tape
7/7/2014 8:44:00 AM - Zacks.com

BIND Therapeutics Ends Oncology Deal with Amgen - Analyst Blog
7/3/2014 4:30:00 PM - Zacks.com

Insys Therapeutics' Epilepsy Therapy Gains FDA Orphan Drug Status - Analyst Blog
7/3/2014 11:30:00 AM - Zacks.com

Salix Pharmaceuticals Surges on Positive IBS Data - Analyst Blog
7/2/2014 6:15:00 PM - Zacks.com

Synageva's Sebelipase Alfa Meets Primary Endpoint in ARISE - Analyst Blog
7/1/2014 4:00:00 PM - Zacks.com

NPS Pharmaceuticals' Gattex Gets Updated Label - Analyst Blog
7/1/2014 11:30:00 AM - Zacks.com

MannKind's Afrezza Approval a Key Milestone - Analyst Blog
6/30/2014 3:18:00 PM - Zacks.com

BioDelivery Progresses with Clonidine Late-Stage Study - Analyst Blog
6/27/2014 6:00:00 PM - Zacks.com

Coronado Falls on TSO Study Results - Analyst Blog
6/27/2014 11:20:00 AM - Zacks.com

Hyperion's Ravicti Submission Accepted in EU - Analyst Blog
6/26/2014 5:20:00 PM - Zacks.com

Auxilium/Sobi's Xiapex Filed for Label Expansion - Analyst Blog
6/26/2014 5:00:00 PM - Zacks.com

2nd Half Of 2014 Biotechnology Catalysts - Part 2
6/25/2014 9:09:00 AM - Seeking Alpha

The Medicines Co.'s Q1 Earnings Surpass Expectations - Analyst Blog
4/24/2014 11:40:01 AM - Zacks.com

The Medicines Co's Fibrocaps Under U.S. Review - Analyst Blog
4/4/2014 6:08:01 PM - Zacks.com